{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T07:30:44Z","timestamp":1767598244935,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007109","name":"Universit\u00e0 degli Studi di Ferrara","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007109","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.humimm.2019.10.003","type":"journal-article","created":{"date-parts":[[2019,11,2]],"date-time":"2019-11-02T00:58:10Z","timestamp":1572656290000},"page":"147-150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Soluble HLA-G pre-transplant levels to identify the risk for development of infection in heart transplant recipients"],"prefix":"10.1016","volume":"81","author":[{"given":"Daria","family":"Bortolotti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Gentili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Rotola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciano","family":"Potena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2019.10.003_b0005","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.critrevonc.2005.03.012","article-title":"Immunosuppressive agents in solid organ transplantation: Mechanisms of action and therapeutic efficacy","volume":"56","author":"Taylor","year":"2005","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.humimm.2019.10.003_b0010","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1086\/510388","article-title":"Opportunistic infections in 547 organ transplant recipients receiving alemtuzumab, a humanized monoclonal CD-52 antibody","volume":"44","author":"Peleg","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.humimm.2019.10.003_b0015","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1086\/510684","article-title":"Rapid detection and identification of bacterial pathogens using novel molecular technologies: infection control and beyond","volume":"44","author":"Tenover","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.humimm.2019.10.003_b0020","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/657625","article-title":"Some basic aspects of HLA-G biology","volume":"2014","author":"Alegre","year":"2014","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.humimm.2019.10.003_b0025","doi-asserted-by":"crossref","first-page":"448","DOI":"10.2174\/187152812803590037","article-title":"New insights into HLA-G and inflammatory diseases","volume":"11","author":"Rizzo","year":"2012","journal-title":"Inflamm. Allergy Drug Targets"},{"key":"10.1016\/j.humimm.2019.10.003_b0030","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1073\/pnas.89.9.3947","article-title":"Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens","volume":"89","author":"Ishitani","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.humimm.2019.10.003_b0035","doi-asserted-by":"crossref","first-page":"9145","DOI":"10.1073\/pnas.84.24.9145","article-title":"A human major histocompatibility complex class I gene that encodes a protein with a shortened cytoplasmic segment","volume":"84","author":"Geraghty","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.humimm.2019.10.003_b0040","doi-asserted-by":"crossref","first-page":"4326495","DOI":"10.1155\/2016\/4326495","article-title":"Recent advances in our understanding of HLA-G biology: lessons from a wide spectrum of human diseases","volume":"2016","author":"Morandi","year":"2016","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.humimm.2019.10.003_b0045","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00018-010-0578-1","article-title":"The importance of HLA-G expression in embryos, trophoblast cells, and embryonic stem cells","volume":"68","author":"Rizzo","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.humimm.2019.10.003_b0050","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1182\/blood-2004-03-0809","article-title":"Erythroblasts secrete the nonclassical HLA-G molecule from primitive to definitive hematopoiesis","volume":"104","author":"Menier","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2019.10.003_b0055","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1084\/jem.186.2.289","article-title":"Identification of a thymic epithelial cell subset sharing expression of the class Ib HLA-G molecule with fetal trophoblasts","volume":"186","author":"Crisa","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.humimm.2019.10.003_b0060","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.humimm.2003.08.346","article-title":"Expression of HLA-G in human cornea, an immune-privileged tissue","volume":"64","author":"Le Discorde","year":"2003","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2019.10.003_b0065","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.2337\/db05-0731","article-title":"The class I HLA repertoire of pancreatic islets comprises the nonclassical class Ib antigen HLA-G","volume":"55","author":"Cirulli","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.humimm.2019.10.003_b0070","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/ajt.12977","article-title":"Role of HLA-G as a predictive marker of low risk of chronic rejection in lung transplant recipients: a clinical prospective study","volume":"15","author":"Brugiere","year":"2015","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2019.10.003_b0075","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.4049\/jimmunol.160.7.3096","article-title":"Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules","volume":"160","author":"Colonna","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2019.10.003_b0080","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2217\/fmb.15.143","article-title":"HLA-G expression and regulation during Pseudomonas aeruginosa infection in cystic fibrosis patients","volume":"11","author":"Rizzo","year":"2016","journal-title":"Future Microbiol"},{"key":"10.1016\/j.humimm.2019.10.003_b0085","doi-asserted-by":"crossref","first-page":"3890306","DOI":"10.1155\/2016\/3890306","article-title":"Study of soluble HLA-G in congenital human cytomegalovirus infection","volume":"2016","author":"Rizzo","year":"2016","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.humimm.2019.10.003_b0090","doi-asserted-by":"crossref","first-page":"8357","DOI":"10.1073\/pnas.0803341105","article-title":"Modulation of dendritic cell differentiation by HLA-G and ILT4 requires the IL-6\u2013STAT3 signaling pathway","volume":"105","author":"Liang","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.humimm.2019.10.003_b0095","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0196-6553(88)90053-3","article-title":"CDC definitions for nosocomial infections, 1988","volume":"16","author":"Garner","year":"1988","journal-title":"Am. J. Infect. Control"},{"key":"10.1016\/j.humimm.2019.10.003_b0100","first-page":"523","article-title":"Production of sHLA-G molecules by in vitro matured cumulus-oocyte complex","volume":"24","author":"Rizzo","year":"2009","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.humimm.2019.10.003_b0105","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1161\/01.CIR.0000015075.89984.46","article-title":"Human leukocyte antigen-G expression after heart transplantation is associated with a reduced incidence of rejection","volume":"105","author":"Lila","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.humimm.2019.10.003_b0110","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/path.1711590305","article-title":"Lymphocyte status in endomyocardial biopsies and blood after heart transplantation","volume":"159","author":"Schuurman","year":"1989","journal-title":"J. Pathol."},{"key":"10.1016\/j.humimm.2019.10.003_b0115","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/210210","article-title":"Antibody-mediated rejection: an evolving entity in heart transplantation","volume":"2012","author":"Chih","year":"2012","journal-title":"J. Transplant"},{"key":"10.1016\/j.humimm.2019.10.003_b0120","first-page":"451","article-title":"HLA-G: immunoregulatory molecule involved in allograft acceptance","volume":"24","author":"Creput","year":"2003","journal-title":"Nephrologie"},{"key":"10.1016\/j.humimm.2019.10.003_b0125","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.healun.2008.01.019","article-title":"Outcome of heart transplants 15 to 20 years ago: graft survival, post-transplant morbidity, and risk factors for mortality","volume":"27","author":"Roussel","year":"2008","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.humimm.2019.10.003_b0130","doi-asserted-by":"crossref","first-page":"304","DOI":"10.4065\/83.3.304","article-title":"Effect of infectious diseases on outcome after heart transplant","volume":"83","author":"van de Beek","year":"2008","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.humimm.2019.10.003_b0135","doi-asserted-by":"crossref","first-page":"592","DOI":"10.3389\/fimmu.2014.00592","article-title":"HLA-G molecules in autoimmune diseases and infections","volume":"5","author":"Rizzo","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2019.10.003_b0140","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jri.2007.02.005","article-title":"Soluble HLA-G molecules in follicular fluid: a tool for oocyte selection in IVF?","volume":"74","author":"Rizzo","year":"2007","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.humimm.2019.10.003_b0145","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/01.fpc.0000230115.41828.3a","article-title":"HLA-G 14-bp polymorphism regulates the methotrexate response in rheumatoid arthritis","volume":"16","author":"Rizzo","year":"2006","journal-title":"Pharmacogenet. Genomics"}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885919310092?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885919310092?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:52:13Z","timestamp":1759319533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885919310092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0198885919310092"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2019.10.003","relation":{},"ISSN":["0198-8859"],"issn-type":[{"type":"print","value":"0198-8859"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Soluble HLA-G pre-transplant levels to identify the risk for development of infection in heart transplant recipients","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2019.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}